Drug Modeling Software Market
SHARE
PUBLISHED: 2021 ID: SMRC20859
SHARE

Drug Modeling Software Market Forecasts to 2028 – Global Analysis By Deployment (On-Premise, Cloud-Based), End User (Research Institutes, Laboratory, Educational Institutes) and By Geography

4.1 (84 reviews)
4.1 (84 reviews)
Published: 2021 ID: SMRC20859

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Drug Modeling Software Market is accounted for $6,707.84 million in 2020 and is expected to reach $14,483.76 million by 2028 growing at a CAGR of 10.1% during the forecast period. Factors such as increasing prevalence of various lifestyle diseases, advancement of information technology, and rising expenditure on healthcare are driving the growth of the market. However, stringent regulations associated with the development and testing of drugs are hampering the growth of the market.

Drug modeling software is used to develop new pharmaceutical drugs and test whether it is effective in treating a particular disease. It is an essential tool in the drug design process as it provides insights of experimental findings and mechanisms of action.

Based on the application, the drug discovery and development segment is anticipated to expand at a rapid pace during the forecast period owing to the need for better therapeutic agents for different diseases. By geography, North America is going to have high growth during the forecast period which can be attributed to the availability of high end technologies and modern infrastructure which helps in carrying out drug modeling effectively.

Some of the key players profiled in the Drug Modeling Software Market include Schrodinger, Inc., Biognos Ab, Crown Bioscience Inc, Acellera Ltd, Dassault Systemes , Chemical Computing Group Ulc, Genedata Ag , Nimbus Therapeutics, Leadscope Inc, and Compugen Ltd.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 6,707.84 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR)  from 2020 to 2028:

10.1%

Predicted 2028 Value:

USD 14,483.76 million

Forecast Years:

2021-2028

Tables, Graphs & Figures

119

Chapters Covered:

Deployment, Product, Application, End User, and Region

Core Drivers and Opportunities:

  • Growing prevalence of lifestyle diseases
  • Rising expenditure on healthcare
  • Advancement of information technology

Restraining Factors & Market Threats:

  • Stringent regulations
  • High costs


Deployments Covered:
• On-Premise
• Cloud-Based

Products Covered:
• Software
• Database
   
Applications Covered:

• Drug Discovery and Development
• Simulation Software
• Disease Modeling
• Predictive Analysis of Drug Targets
• Computational Physiological Medicine
• Cellular Simulation
• Medical Imaging   

End Users Covered:
• Research Institutes
• Laboratory
• Educational Institutes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Drug Modeling Software Market is majorly driven by the increasing prevalence of various lifestyle diseases, advancement of information technology, and rising expenditure on healthcare.

The software segment is growing at a highest CAGR as it offers cost-effective drug discovery and designing methods thereby helping the expansion of new bio-active drugs.

North America dominated with a significant market share due to the factors such as the availability of high end technologies and presence of modern infrastructure in the region.

Asia Pacific market is growing at a highest CAGR owing to the increasing geriatric population and growing awareness regarding the benefits of therapeutic drugs.

Key players in Drug Modeling Software Market include Schrodinger, Inc., Biognos Ab, Crown Bioscience Inc, Acellera Ltd, Dassault Systemes , Chemical Computing Group Ulc, Genedata Ag , Nimbus Therapeutics, Leadscope Inc, and Compugen Ltd.

Table of Contents

1 Executive Summary     
       
2 Preface      

 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints     
 3.4 Opportunities    
 3.5 Threats     
 3.6 Product Analysis    
 3.7 Application Analysis    
 3.8 End User Analysis    
 3.9 Emerging Markets    
 3.10 Impact of Covid-19    
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes    
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Drug Modeling Software Market, By Deployment 
 5.1 Introduction    
 5.2 On-Premise    
 5.3 Cloud-Based    
       
6 Global Drug Modeling Software Market, By Product  
 6.1 Introduction    
 6.2 Software     
 6.3 Database     
       
7 Global Drug Modeling Software Market, By Application 
 7.1 Introduction    
 7.2 Drug Discovery and Development  
 7.3 Simulation Software    
 7.4 Disease Modeling    
 7.5 Predictive Analysis of Drug Targets  
 7.6 Computational Physiological Medicine  
 7.7 Cellular Simulation    
 7.8 Medical Imaging    
       
8 Global Drug Modeling Software Market, By End User 

 8.1 Introduction    
 8.2 Research Institutes    
 8.3 Laboratory    
 8.4 Educational Institutes   
       
9 Global Drug Modeling Software Market, By Geography 
 9.1 Introduction    
 9.2 North America    
  9.2.1 US    
  9.2.2 Canada    
  9.2.3 Mexico    
 9.3 Europe     
  9.3.1 Germany    
  9.3.2 UK    
  9.3.3 Italy    
  9.3.4 France    
  9.3.5 Spain    
  9.3.6 Rest of Europe    
 9.4 Asia Pacific    
  9.4.1 Japan    
  9.4.2 China    
  9.4.3 India    
  9.4.4 Australia    
  9.4.5 New Zealand   
  9.4.6 South Korea   
  9.4.7 Rest of Asia Pacific   
 9.5 South America    
  9.5.1 Argentina    
  9.5.2 Brazil    
  9.5.3 Chile    
  9.5.4 Rest of South America  
 9.6 Middle East & Africa    
  9.6.1 Saudi Arabia   
  9.6.2 UAE    
  9.6.3 Qatar    
  9.6.4 South Africa   
  9.6.5 Rest of Middle East & Africa  
       
10 Key Developments     
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers   
 10.3 New Product Launch    
 10.4 Expansions    
 10.5 Other Key Strategies    
       
11 Company Profiling     
 11.1 Schrodinger, Inc.    
 11.2 Biognos Ab    
 11.3 Crown Bioscience Inc   
 11.4 Acellera Ltd    
 11.5 Dassault Systemes    
 11.6 Chemical Computing Group Ulc   
 11.7 Genedata Ag    
 11.8 Nimbus Therapeutics    
 11.9 Leadscope Inc    
 11.10 Compugen Ltd    


List of Tables       
1 Global Drug Modeling Software Market Outlook, By Region (2019-2028) ($MN)
2 Global Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
3 Global Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
4 Global Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
5 Global Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
6 Global Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
7 Global Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
8 Global Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
9 Global Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
10 Global Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
11 Global Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
12 Global Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
13 Global Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
14 Global Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
15 Global Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
16 Global Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
17 Global Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
18 Global Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
19 Global Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
20 North America Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
21 North America Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
22 North America Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
23 North America Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
24 North America Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
25 North America Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
26 North America Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
27 North America Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
28 North America Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
29 North America Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
30 North America Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
31 North America Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
32 North America Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
33 North America Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
34 North America Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
35 North America Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
36 North America Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
37 North America Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
38 North America Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
39 Europe Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
40 Europe Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
41 Europe Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
42 Europe Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
43 Europe Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
44 Europe Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
45 Europe Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
46 Europe Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
47 Europe Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
48 Europe Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
49 Europe Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
50 Europe Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
51 Europe Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
52 Europe Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
53 Europe Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
54 Europe Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
55 Europe Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
56 Europe Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
57 Europe Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
58 Asia Pacific Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
59 Asia Pacific Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
60 Asia Pacific Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
61 Asia Pacific Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
62 Asia Pacific Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
63 Asia Pacific Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
64 Asia Pacific Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
65 Asia Pacific Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
66 Asia Pacific Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
67 Asia Pacific Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
68 Asia Pacific Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
69 Asia Pacific Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
70 Asia Pacific Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
71 Asia Pacific Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
72 Asia Pacific Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
73 Asia Pacific Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
74 Asia Pacific Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
75 Asia Pacific Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
76 Asia Pacific Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
77 South America Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
78 South America Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
79 South America Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
80 South America Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
81 South America Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
82 South America Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
83 South America Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
84 South America Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
85 South America Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
86 South America Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
87 South America Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
88 South America Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
89 South America Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
90 South America Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
91 South America Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
92 South America Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
93 South America Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
94 South America Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
95 South America Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)
96 Middle East & Africa Drug Modeling Software Market Outlook, By Country (2019-2028) ($MN)
97 Middle East & Africa Drug Modeling Software Market Outlook, By Deployment (2019-2028) ($MN)
98 Middle East & Africa Drug Modeling Software Market Outlook, By On-Premise (2019-2028) ($MN)
99 Middle East & Africa Drug Modeling Software Market Outlook, By Cloud-Based (2019-2028) ($MN)
100 Middle East & Africa Drug Modeling Software Market Outlook, By Product (2019-2028) ($MN)
101 Middle East & Africa Drug Modeling Software Market Outlook, By Software (2019-2028) ($MN)
102 Middle East & Africa Drug Modeling Software Market Outlook, By Database (2019-2028) ($MN)
103 Middle East & Africa Drug Modeling Software Market Outlook, By Application (2019-2028) ($MN)
104 Middle East & Africa Drug Modeling Software Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
105 Middle East & Africa Drug Modeling Software Market Outlook, By Simulation Software (2019-2028) ($MN)
106 Middle East & Africa Drug Modeling Software Market Outlook, By Disease Modeling (2019-2028) ($MN)
107 Middle East & Africa Drug Modeling Software Market Outlook, By Predictive Analysis of Drug Targets (2019-2028) ($MN)
108 Middle East & Africa Drug Modeling Software Market Outlook, By Computational Physiological Medicine (2019-2028) ($MN)
109 Middle East & Africa Drug Modeling Software Market Outlook, By Cellular Simulation (2019-2028) ($MN)
110 Middle East & Africa Drug Modeling Software Market Outlook, By Medical Imaging (2019-2028) ($MN)
111 Middle East & Africa Drug Modeling Software Market Outlook, By End User (2019-2028) ($MN)
112 Middle East & Africa Drug Modeling Software Market Outlook, By Research Institutes (2019-2028) ($MN)
113 Middle East & Africa Drug Modeling Software Market Outlook, By Laboratory (2019-2028) ($MN)
114 Middle East & Africa Drug Modeling Software Market Outlook, By Educational Institutes (2019-2028) ($MN)

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials